GJB2 p.Gly4Val
Variant summary
The NM_004004.6(GJB2):c.11G>T (p.Gly4Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene GJB2 is a tumor suppressor gene (CancerMine: 5 TSG, 1 oncogene citations). The gene GJB2 is a known oncogene (CancerMine: 5 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000274 (AC=4) in the gnomAD database across 1,461,778 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000084. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.G4D: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 44724)
Frequency
Consequence
NM_004004.6 missense
Scores
Clinical Significance
Conservation
Publications
- Bart-Pumphrey syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- hearing loss disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- ichthyosis, hystrix-like, with hearing lossInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
- keratoderma hereditarium mutilansInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- palmoplantar keratoderma-deafness syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- autosomal recessive nonsyndromic hearing loss 1AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant keratitis-ichthyosis-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, PanelApp Australia
- autosomal dominant nonsyndromic hearing loss 3AInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- KID syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 3 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000001 — very rare (O3 supporting [+1]) | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 5 pathogenic, 0 benign (OR vs. background: 55.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.44 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_004004.6. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
GJB2 | TSL:1MANE Select | c.11G>T p.Gly4Val | missense | Exon 2 of 2 | Prot: ENSP00000372299.4 UniProt: | |
GJB2 | TSL:6 | c.11G>T p.Gly4Val | missense | Exon 1 of 1 | Prot: ENSP00000372295.1 UniProt: | |
GJB2 | c.11G>T p.Gly4Val | missense | Exon 2 of 2 | Prot: ENSP00000576289.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD2 exomes | AF: 0.0000120 | AC:3 | AN:249290 | ||
GnomAD4 exome | AF: 0.00000274 | AC:4 | Hom:0 | AN:1461778 | Cov:32 |
GnomAD4 genome | Cov:33 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 19 | |
AlphaMissense | Benign | 0.19 | |
BayesDel_addAF | Uncertain | 0.024 | T |
BayesDel_noAF | Benign | -0.14 | |
CADD | Benign | 18 | |
DANN | Benign | 0.89 | |
DEOGEN2 | Uncertain | 0.77 | D |
Eigen | Benign | -0.46 | |
Eigen_PC | Benign | -0.46 | |
FATHMM_MKL | Benign | 0.69 | D |
FuncVEP CTI | Benign | 0.023 | |
GPN-Star LLR | N/A | -6.1 | |
GPN-Star score | N/A | 6.1 | |
LIST_S2 | Benign | 0.81 | T |
M_CAP | Uncertain | 0.17 | D |
MetaRNN | Benign | 0.40 | T |
MetaSVM | Pathogenic | 0.95 | D |
Mutation Taster | N/A | 94/6 | polymorphism |
MutationAssessor | Uncertain | 2.7 | M |
PhyloP100 | Benign | 0.41 | |
popEVE | Benign | -3.0 | |
PrimateAI | Benign | 0.39 | T |
PromoterAI | N/A | 0.065 | Neutral |
PROVEAN | Uncertain | -2.4 | N |
REVEL | Uncertain | 0.40 | |
Sift | Benign | 0.094 | T |
Sift4G | Benign | 0.11 | T |
Varity_R | N/A | 0.58 | |
VESM-3B | Benign | -7.7 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.